US government to pay Pfizer $2B for COVID-19 vaccine by end of year


The United States is far from alone in the development of a COVID-19 vaccine, with multiple countries launching small-scale studies and testing their own vaccines. Britain recently purchased 90 million doses of an experimental vaccine developed by Pfizer and others. While in China, multiple vaccine candidates have reached final testing stages.

In a Tuesday briefing on the COVID-19 pandemic, President Trump commented on the notion of there being a vaccine in the near future, “the vaccines are coming, and they’re coming a lot sooner than anyone thought possible, by years.”

Only time will tell if a viable vaccine will be developed to meet the January, 2021, window proposed by President Trump. Until then, Americans will continue to follow public health guidelines such as masks and social distancing.


Have a story you want USA Herald to cover? Submit a tip here and if we think it’s newsworthy, we’ll follow up on it.

Want guaranteed coverage? We also offer contract journalism here.  Just be sure you’re comfortable giving up editorial control, because our journalists are dogged and will follow the story through to it’s conclusion. The story will be published to our exacting standards, without regard for your preferred slant.